A selective androgen receptor modulator, S4, displays robust anti-cancer activity on hepatocellular cancer cells by negatively regulating PI3K/AKT/mTOR signalling pathway - ScienceDirect
4.8
$ 8.00
In stock
(725)
Product Description
Targeting the PI3K/Akt pathway in prostate cancer: Challenges and
Hepatocellular Carcinoma Overview - Signaling Pathway. Diagnosis
TRPM8-regulated calcium mobilization plays a critical role in
Targeting AKT with costunolide suppresses the growth of colorectal
B7-H3 immune checkpoint expression is a poor prognostic factor in
Autocrine STAT3 activation in HPV positive cervical cancer through
Paeonol induces cytoprotective autophagy via blocking the Akt/mTOR
Clinical development of therapies targeting TGFβ: current
IJMS, Free Full-Text
